Medtronic EVP Harry Skip Kiil Sells $139K in Company Stock
Medtronic plc
Subscribe to track MDT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Medtronic EVP Harry Skip Kiil Sells $139K in Company Stock
Company: Medtronic plc (MDT)
Form: 4 | Filed: 2026-09-17
Significance: Low
Insider: Harry Skip Kiil Title: EVP & President Cardiovascular | Relationship: Officer
Transaction Details: • Type: Sell (Open Market) • Shares: 1,483 • Price: $93.65 • Value: $138,882.95 • Shares Owned After: 42,186
Key Insight: Routine and minor sale representing approximately 3.4% of the executive's direct holdings and less than 0.0002% of MDT's shares outstanding.
Market Context: Medtronic carries a mega-cap valuation of $119.98B, rendering this transaction immaterial to broader stock performance.
Comprehensive Analysis
SEC Filing Analysis: Medtronic plc (MDT)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Executive Vice President Harry Skip Kiil sold 1,483 ordinary shares for approximately $138.9K, reducing his direct position by ~3.4%.
- Market Impact: Neutral; transaction size is negligible relative to Medtronic's $119.98B market capitalization.
Company Information
| Field | Value |
|---|---|
| Company | Medtronic plc |
| Ticker Symbol | MDT |
| CIK | 0001613103 |
| Industry | Electromedical & Electrotherapeutic Apparatus |
Insider Information
| Field | Value |
|---|---|
| Name | Harry Skip Kiil |
| CIK | 0001708062 |
| Title/Position | EVP & President Cardiovascular |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-09-16 |
| Transaction Code | S (Open market sale) |
| Security Type | Ordinary Shares |
| Shares Involved | 1,483 |
| Price Per Share | $93.65 |
| Total Value | $138,882.95 |
| Shares Owned After | 42,186 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $138,882.95 |
| % of Market Cap | 0.0001% |
| Shares Transacted | 1,483 |
| % of Shares Outstanding | 0.0001% |
| Post-Transaction Ownership | 42,186 shares (0.0033% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: Across Medtronic's $119.98B market capitalization and 1.28B shares outstanding, a transaction of under $140K is immaterial for retail or institutional investors.
- Ownership Concentration: Harry Skip Kiil maintains 42,186 shares directly, valued at roughly $3.95M, retaining over 96.6% of his pre-transaction equity holdings.
- Transaction Significance: Low significance under standard SEC analysis metrics (<0.1% market cap and <0.1% shares outstanding).
Market Impact Analysis
- Direction: Neutral
- Reasoning: The trade represents a minor liquidity event for the officer and has no bearing on core operational performance or balance sheet fundamentals.
- Expected Volume Impact: Negligible; daily trading volume in MDT vastly exceeds the 1,483 shares sold.
- Sentiment Indicator: Neutral
Additional Context
- Timing: Executed on September 16, 2026, and filed on September 17, 2026.
- Special Circumstances: The filing indicates aff10b5One is marked as 0, indicating this sale was not executed under a Rule 10b5-1 trading plan.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.